S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7118 +0.12%
AFTER HRS · 19:05 ET
Market ClerkRecap
Wed Oct 21 · after hours2 signals today106 insider buys this week · $305.5MCIRO short report next: Oct 31The week ahead

ALKS

Alkermes plc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
43.48
−0.63 −1.43%
USD · close Oct 21

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $7.3BP/E 114.4DIV YIELD —FCF YIELD 3.04%REV TTM $1.7B +10.8%NET INCOME $66.1M −81.0%NET DEBT $1B52W 27.20 – 55.22NEXT EARNINGS Oct 28 EST.SEC XBRL · TTM TO Invalid Date

What ALKS had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
FiledWhat was reportedEvent dateDocument
Sep 21Other eventReg FD disclosureSep 21open on EDGAR ↗
Sep 16Officer or director changeReg FD disclosureSep 14open on EDGAR ↗

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch ALKS. Know when insiders buy.
One email the day a filing lands. Free.